Latest Breaking News On - Head of global corporate communications marketing - Page 1 : vimarsana.com

Evotec SE: Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany

EXPANSION OF CGMP DRUG SUBSTANCE MANUFACTURING PLATFORM WILL CREATE A CLEAR PATH TO THE MARKET FOR RARE DISEASES AND PRECISION THERAPEUTICSEVOTEC GAINS A FULLY OPERATIONAL EU GMP CERTIFIED FACILITY IN

Volker braunWerner lanthalerGabriele hansenCentral glass coHead of global corporate communications marketingEvotec se frankfurt stock exchangeFrankfurt stock exchangeCentral glass germany gmbhCentral glassEvotec drug substanceChief executive officerGlobal corporate communicationsGlobal investor relations

DGAP-News: Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany

DGAP-News: EVOTEC SE / Key word(s): Miscellaneous Evotec expands clinical and commercial drug substance manufacturing with acquisitio.

Volker braunWerner lanthalerGabriele hansenCentral glass coHead of global corporate communications marketingEvotec se frankfurt stock exchangeDistribution servicesCentral glass germanyFrankfurt stock exchangeCentral glass germany gmbhCentral glassEvotec drug substanceChief executive officerData driven rd autobahnGlobal corporate communicationsGlobal investor relations

Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany

Press release content from Accesswire. The AP news staff was not involved in its creation.

Volker braunWerner lanthalerGabriele hansenCentral glass coHead of global corporate communications marketingEvotec se frankfurt stock exchangeFrankfurt stock exchangeCentral glass germany gmbhCentral glassEvotec drug substanceChief executive officerGlobal corporate communicationsGlobal investor relationsPharmaceutical manufacturing

Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glas

DGAP-News: Evotec SE / Key word(s): MiscellaneousEvotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany 25.08.2022 / 07:31 CET/CESTThe issuer is solely responsible for the content of this announcement. EXPANSION OF CGMP DRUG SUBSTANCE MANUFACTURING PLATFORM WILL.

Volker braunWerner lanthalerGabriele hansenCentral glass coHead of global corporate communications marketingEvotec se frankfurt stock exchangeDistribution servicesCentral glass germanyFrankfurt stock exchangeCentral glass germany gmbhCentral glassEvotec drug substanceChief executive officerGlobal corporate communicationsGlobal investor relationsCorporate news

Just - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303

Just - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesVolker braunEvotec biologicsLinda zuckermanGabriele hansenWayne gombotzCraig johnstoneAlpine immune sciencesAlpine immune sciences incEvotec se frankfurt stock exchangeExchange commissionEvotec biologics incHead of global corporate communications marketingWall streetFrankfurt stock exchangeExecutive vice president